151 related articles for article (PubMed ID: 18622269)
21. CD40 and its ligand in atherosclerosis.
Lutgens E; Lievens D; Beckers L; Donners M; Daemen M
Trends Cardiovasc Med; 2007 May; 17(4):118-23. PubMed ID: 17482093
[TBL] [Abstract][Full Text] [Related]
22. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
[TBL] [Abstract][Full Text] [Related]
23. [Effect of CD40 blockade on acute renal graft rejection in rats].
Shi XH; Liu XY; Sun XY; Zhao M
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2085-6. PubMed ID: 22200719
[TBL] [Abstract][Full Text] [Related]
24. Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD40/CD154 pathway and donor MHC disparity.
Luo B; Wu T; Pan Y; Sozen H; Hao J; Zhang Y; Sutherland DE; Hering BJ; Guo Z
Ann N Y Acad Sci; 2007 Apr; 1103():94-102. PubMed ID: 17376827
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of binding activity of soluble human CD40 to CD40 ligand through incorporation of an isoleucine zipper motif.
He XH; Xu LH; Liu Y
Acta Pharmacol Sin; 2006 Mar; 27(3):333-8. PubMed ID: 16490170
[TBL] [Abstract][Full Text] [Related]
26. Extracellular HSP70 blocks CD40L-induced apoptosis and tubular formation in endothelial cells.
Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Horie A; Ueki N; Kusunoki M; Gudis K; Miyake K; Tsukui T; Sakamoto C
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S222-8. PubMed ID: 19120902
[TBL] [Abstract][Full Text] [Related]
27. [Blockade of CD40/CD154 signal as a therapeutic strategy for autoimmune diseases].
Kuwana M
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Oct; 26(5):259-66. PubMed ID: 14635399
[No Abstract] [Full Text] [Related]
28. [CD 40 L blockade as a novel treatment for chronic ITP refractory to corticosteroids and splenectomy].
Kuwana M
Rinsho Ketsueki; 2003 Feb; 44(2):82-9. PubMed ID: 12692980
[No Abstract] [Full Text] [Related]
29. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
Tung TH; Mackinnon SE; Mohanakumar T
Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
[TBL] [Abstract][Full Text] [Related]
30. Combining regulation with suppression and aiming for tolerance.
Cobbold SP
Transplantation; 2010 Apr; 89(8):909-10. PubMed ID: 20216484
[No Abstract] [Full Text] [Related]
31. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases.
Xie JH; Yamniuk AP; Borowski V; Kuhn R; Susulic V; Rex-Rabe S; Yang X; Zhou X; Zhang Y; Gillooly K; Brosius R; Ravishankar R; Waggie K; Mink K; Price L; Rehfuss R; Tamura J; An Y; Cheng L; Abramczyk B; Ignatovich O; Drew P; Grant S; Bryson JW; Suchard S; Salter-Cid L; Nadler S; Suri A
J Immunol; 2014 May; 192(9):4083-92. PubMed ID: 24670803
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II modulates CD40 expression in vascular smooth muscle cells.
Souza HP; Frediani D; Cobra AL; Moretti AI; Jurado MC; Fernandes TR; Cardounel AJ; Zweier JL; Tostes RC
Clin Sci (Lond); 2009 Mar; 116(5):423-31. PubMed ID: 18785879
[TBL] [Abstract][Full Text] [Related]
33. IDEC-131. IDEC/Eisai.
Dumont FJ
Curr Opin Investig Drugs; 2002 May; 3(5):725-34. PubMed ID: 12090546
[TBL] [Abstract][Full Text] [Related]
34. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.
Anwar IJ; Berman DM; DeLaura I; Gao Q; Willman MA; Miller A; Gill A; Gill C; Perrin S; Ricordi C; Ruiz P; Song M; Ladowski JM; Kirk AD; Kenyon NS
Sci Transl Med; 2023 Aug; 15(711):eadf6376. PubMed ID: 37647390
[TBL] [Abstract][Full Text] [Related]
35. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in CD40 and its functional characterization.
Qi CJ; Zheng L; Ma HB; Fei M; Qian KQ; Shen BR; Wu CP; Vihinen M; Zhang XG
Hum Mutat; 2009 Jun; 30(6):985-94. PubMed ID: 19479954
[TBL] [Abstract][Full Text] [Related]
37. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
38. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
Zhang X; Kedl RM; Xiang J
Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
[TBL] [Abstract][Full Text] [Related]
39. Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies.
Khubchandani S; Czuczman MS; Hernandez-Ilizaliturri FJ
Curr Opin Investig Drugs; 2009 Jun; 10(6):579-87. PubMed ID: 19513947
[TBL] [Abstract][Full Text] [Related]
40. Fc-disabled anti-mouse CD40L antibodies retain efficacy in promoting transplantation tolerance.
Daley SR; Cobbold SP; Waldmann H
Am J Transplant; 2008 Nov; 8(11):2265-71. PubMed ID: 18782294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
